NCT01171963View on ClinicalTrials.gov

Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

3,340

Participants

Timeline

Start Date

August 29, 2010

Primary Completion Date

May 12, 2012

Study Completion Date

May 12, 2012

Conditions
Infections, Rotavirus
Interventions
BIOLOGICAL

GSK Biologicals' liquid human rotavirus vaccine 444563

Oral administration

BIOLOGICAL

Placebo

Oral administration

BIOLOGICAL

Infanrix™

Intramuscular administration

BIOLOGICAL

Institute of Medical Biology Chinese Academy of Medical Sciences' Oral poliovirus vaccine (OPV)

Oral administration

Trial Locations (4)

545100

GSK Investigational Site, Liuzhou

545200

GSK Investigational Site, Liucheng County

545600

GSK Investigational Site, Luzhai County

547000

GSK Investigational Site, Hechi

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01171963 - Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants | Biotech Hunter | Biotech Hunter